Literature DB >> 10662865

Potential bias in Kaplan-Meier survival analysis applied to rheumatology drug studies.

M Utley, S Gallivan, A Young, N Cox, P Davies, J Dixey, P Emery, A Gough, D James, P Prouse, P Williams, J Winfield, J A Devlin.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10662865     DOI： 10.1093/rheumatology/39.1.1

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

1.  Letter to the editor: Do "premium" joint implants add value?: analysis of high cost joint implants in a community registry.

Authors:  Michael McClure; Peter Heeckt
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

2.  Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden.

Authors:  Lars Erik Kristensen; Tore Saxne; Jan-Ake Nilsson; Pierre Geborek
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.